Table 4.
Characteristics | Univariate Analysis | Multivariate Analysis | |||
---|---|---|---|---|---|
HR | P Value | HR | P Value | 95% CI | |
Age | |||||
< 50 y | Referent | Referent | |||
50 y | 0.4 | <0.0001 | 0.5 | 0.004 | 0.3–0.8 |
IM drainage | 1.6 | 0.08 | 1.3 | 0.2 | 0.8–2.2 |
UOQ tumor location | 0.9 | 0.8 | |||
Medial tumor location | 1.4 | 0.2 | 1.5 | 0.2 | 0.8–2.9 |
LVI | 1.3 | 0.4 | |||
Nuclear grade | |||||
1 | Referent | ||||
2 | 0.8 | 0.6 | 0.6 | 0.2 | 0.2–1.3 |
3 | 1.8 | 0.1 | 0.7 | 0.4 | 0.3–1.7 |
Tumor stage | |||||
T1 | Referent | ||||
T2 | 1.6 | 0.08 | 1.4 | 0.2 | 0.8–2.5 |
T3 | 2.3 | 0.2 | 2.5 | 0.2 | 0.7–9.5 |
Negative ER status | 3.4 | <0.0001 | 3.2 | <0.0001 | 1.9–5.1 |
Negative PR status | 2.0 | 0.005 | 1.3 | 0.4 | 0.7–2.2 |
Negative HER-2 status | 0.8 | 0.5 | |||
Tumor histology | |||||
IDC | Referent | ||||
ILC | 0.5 | .2 | 0.6 | 0.4 | 0.2–2.1 |
IDC and ILC | 0.6 | .3 | 0.9 | 0.8 | 0.3–2.3 |
Other | 0.3 | .1 | 0.3 | 0.2 | 0.1–1.5 |
Number of positive LNsa | 1.0 | .9 |
HR indicates hazards ratio; CI, confidence interval; IM, internal mammary; UOQ, upper outer quadrant; LVI, lymphovascular invasion; ER, estrogen receptor; PR, progesterone receptor; IDC, invasive ductal carcinoma; ILC, invasive lobular carcinoma; LN, lymph node.
As a continuous variable.